• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用系统发生方法研究癌症体细胞突变过程的进化。

A phylogenetic approach to study the evolution of somatic mutational processes in cancer.

机构信息

Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA.

Department of Biology, Temple University, Philadelphia, PA, USA.

出版信息

Commun Biol. 2022 Jun 22;5(1):617. doi: 10.1038/s42003-022-03560-0.

DOI:10.1038/s42003-022-03560-0
PMID:35732905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9217972/
Abstract

Cancer cell genomes change continuously due to mutations, and mutational processes change over time in patients, leaving dynamic signatures in the accumulated genomic variation in tumors. Many computational methods detect the relative activities of known mutation signatures. However, these methods may produce erroneous signatures when applied to individual branches in cancer cell phylogenies. Here, we show that the inference of branch-specific mutational signatures can be improved through a joint analysis of the collections of mutations mapped on proximal branches of the cancer cell phylogeny. This approach reduces the false-positive discovery rate of branch-specific signatures and can sometimes detect faint signatures. An analysis of empirical data from 61 lung cancer patients supports trends based on computer-simulated datasets for which the correct signatures are known. In lung cancer somatic variation, we detect a decreasing trend of smoking-related mutational processes over time and an increasing influence of APOBEC mutational processes as the tumor evolution progresses. These analyses also reveal patterns of conservation and divergence of mutational processes in cell lineages within patients.

摘要

由于突变,癌细胞的基因组不断变化,并且在患者中,突变过程随时间而变化,在肿瘤中积累的基因组变异中留下了动态特征。许多计算方法可以检测已知突变特征的相对活性。然而,当将这些方法应用于癌症细胞系统发育的单个分支时,可能会产生错误的特征。在这里,我们表明,通过对癌症细胞系统发育近端分支上映射的突变集合进行联合分析,可以改善分支特异性突变特征的推断。这种方法降低了分支特异性特征的假阳性发现率,有时还可以检测到微弱的特征。对来自 61 位肺癌患者的经验数据的分析支持了基于计算机模拟数据集的趋势,而这些模拟数据集中已知正确的特征。在肺癌体细胞变异中,我们检测到随着时间的推移,与吸烟相关的突变过程呈下降趋势,而 APOBEC 突变过程的影响随着肿瘤的进化而增加。这些分析还揭示了患者内细胞谱系中突变过程的保守和发散模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/9a9054fb95fb/42003_2022_3560_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/dce2843beda1/42003_2022_3560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/e6bea1bddfb6/42003_2022_3560_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/0cf79de4c932/42003_2022_3560_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/8aff1c26e629/42003_2022_3560_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/e8ca53bcd4d8/42003_2022_3560_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/c3d3493abc45/42003_2022_3560_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/f499dde2ff79/42003_2022_3560_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/9a9054fb95fb/42003_2022_3560_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/dce2843beda1/42003_2022_3560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/e6bea1bddfb6/42003_2022_3560_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/0cf79de4c932/42003_2022_3560_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/8aff1c26e629/42003_2022_3560_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/e8ca53bcd4d8/42003_2022_3560_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/c3d3493abc45/42003_2022_3560_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/f499dde2ff79/42003_2022_3560_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69cd/9217972/9a9054fb95fb/42003_2022_3560_Fig8_HTML.jpg

相似文献

1
A phylogenetic approach to study the evolution of somatic mutational processes in cancer.运用系统发生方法研究癌症体细胞突变过程的进化。
Commun Biol. 2022 Jun 22;5(1):617. doi: 10.1038/s42003-022-03560-0.
2
Topography of mutational signatures in non-small cell lung cancer: emerging concepts, clinical applications, and limitations.非小细胞肺癌中突变特征的拓扑结构:新兴概念、临床应用及局限性。
Oncologist. 2024 Oct 3;29(10):833-841. doi: 10.1093/oncolo/oyae091.
3
Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.基于网络的方法阐明了乳腺癌中 APOBEC 和时钟样特征的差异。
Genome Med. 2020 May 29;12(1):52. doi: 10.1186/s13073-020-00745-2.
4
Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.对 7815 个癌症外显子组的分析揭示了突变过程与体细胞驱动突变之间的关联。
PLoS Genet. 2018 Nov 9;14(11):e1007779. doi: 10.1371/journal.pgen.1007779. eCollection 2018 Nov.
5
Patterns and processes of somatic mutations in nine major cancers.九大常见癌症中的体细胞突变模式和过程。
BMC Med Genomics. 2014 Feb 19;7:11. doi: 10.1186/1755-8794-7-11.
6
decompTumor2Sig: identification of mutational signatures active in individual tumors.decompTumor2Sig:鉴定个体肿瘤中活跃的突变特征。
BMC Bioinformatics. 2019 Apr 18;20(Suppl 4):152. doi: 10.1186/s12859-019-2688-6.
7
Computational tools to detect signatures of mutational processes in DNA from tumours: A review and empirical comparison of performance.用于检测肿瘤 DNA 中突变过程特征的计算工具:性能的回顾和实证比较。
PLoS One. 2019 Sep 12;14(9):e0221235. doi: 10.1371/journal.pone.0221235. eCollection 2019.
8
Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.突变特征揭示了同源重组修复、APOBEC 和错配修复在妇科癌症中的三元关系。
J Transl Med. 2022 Feb 2;20(1):65. doi: 10.1186/s12967-022-03259-0.
9
Clinical and genomic characterization of mutational signatures across human cancers.人类癌症中突变特征的临床和基因组特征。
Int J Cancer. 2023 Apr 15;152(8):1613-1629. doi: 10.1002/ijc.34402. Epub 2023 Jan 6.
10
Influence network model uncovers relations between biological processes and mutational signatures.影响网络模型揭示了生物过程与突变特征之间的关系。
Genome Med. 2023 Mar 6;15(1):15. doi: 10.1186/s13073-023-01162-x.

引用本文的文献

1
GenoPath: a pipeline to infer tumor clone composition, mutational history, and metastatic cell migration events from tumor DNA sequencing data.GenoPath:一种从肿瘤DNA测序数据推断肿瘤克隆组成、突变历史和转移细胞迁移事件的流程。
Front Bioinform. 2025 Jul 2;5:1615834. doi: 10.3389/fbinf.2025.1615834. eCollection 2025.
2
Inferring active mutational processes in cancer using single cell sequencing and evolutionary constraints.利用单细胞测序和进化限制推断癌症中的活跃突变过程。
bioRxiv. 2025 Feb 27:2025.02.24.639589. doi: 10.1101/2025.02.24.639589.
3
Cell-cell fusion in cancer: The next cancer hallmark?

本文引用的文献

1
CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data.CloneSig 可以联合推断肿瘤测序数据中的肿瘤内异质性和突变特征活性。
Nat Commun. 2021 Sep 9;12(1):5352. doi: 10.1038/s41467-021-24992-y.
2
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.分析 2658 个人类癌症基因组中的遗传肿瘤内异质性。
Cell. 2021 Apr 15;184(8):2239-2254.e39. doi: 10.1016/j.cell.2021.03.009. Epub 2021 Apr 7.
3
Using sigLASSO to optimize cancer mutation signatures jointly with sampling likelihood.
细胞融合与癌症:下一个癌症标志?
Int J Biochem Cell Biol. 2024 Oct;175:106649. doi: 10.1016/j.biocel.2024.106649. Epub 2024 Aug 24.
4
Improving cellular phylogenies through the integrated use of mutation order and optimality principles.通过综合运用突变顺序和最优性原则改进细胞系统发育树
Comput Struct Biotechnol J. 2023 Aug 2;21:3894-3903. doi: 10.1016/j.csbj.2023.07.018. eCollection 2023.
5
Bootstrap confidence for molecular evolutionary estimates from tumor bulk sequencing data.肿瘤全基因组测序数据分子进化估计的自展置信度
Front Bioinform. 2023 May 16;3:1090730. doi: 10.3389/fbinf.2023.1090730. eCollection 2023.
6
Timed hazard networks: Incorporating temporal difference for oncogenetic analysis.定时风险网络:纳入时变差异进行oncogenetic 分析。
PLoS One. 2023 Mar 16;18(3):e0283004. doi: 10.1371/journal.pone.0283004. eCollection 2023.
使用 sigLASSO 联合采样可能性优化癌症突变特征。
Nat Commun. 2020 Jul 17;11(1):3575. doi: 10.1038/s41467-020-17388-x.
4
Power and pitfalls of computational methods for inferring clone phylogenies and mutation orders from bulk sequencing data.从批量测序数据中推断克隆进化关系和突变顺序的计算方法的优势和陷阱。
Sci Rep. 2020 Feb 26;10(1):3498. doi: 10.1038/s41598-020-59006-2.
5
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
6
The evolutionary history of 2,658 cancers.2658 种癌症的进化史。
Nature. 2020 Feb;578(7793):122-128. doi: 10.1038/s41586-019-1907-7. Epub 2020 Feb 6.
7
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.利用 TrackSig 重建癌症中突变特征活动的进化轨迹。
Nat Commun. 2020 Feb 5;11(1):731. doi: 10.1038/s41467-020-14352-7.
8
PhySigs: Phylogenetic Inference of Mutational Signature Dynamics.PhySigs:突变特征动态的系统发育推断。
Pac Symp Biocomput. 2020;25:226-237.
9
A practical guide for mutational signature analysis in hematological malignancies.血液系统恶性肿瘤突变特征分析实用指南
Nat Commun. 2019 Jul 5;10(1):2969. doi: 10.1038/s41467-019-11037-8.
10
Portrait of a cancer: mutational signature analyses for cancer diagnostics.癌症画像:基因突变特征分析在癌症诊断中的应用。
BMC Cancer. 2019 May 15;19(1):457. doi: 10.1186/s12885-019-5677-2.